ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2023

Dec 19, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2023-12-15

Reporting Person: Vakiener Victoria (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-15	Common Stock	A	14987	$25.41	Acquired	36721	Direct

Footnotes

F1: Represents shares underlying restricted stock units, which will vest in one installment on the first anniversary date.